Biosimilar Lucentis Sponsors Had To Navigate Different FDA, EMA Requirements

 
• By Sue Sutter
  
Drug Review Profile: Lucentis biosimilars
Biosimillar sponsors had to navigate the different preferences of the US and European regulators. • Source: Shutterstock/Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Review Profiles

More from Product Reviews